Used primarily in pharmaceutical research as a potent and selective inhibitor of soluble epoxide hydrolase (sEH), this compound plays a key role in modulating biological pathways related to inflammation, pain, and cardiovascular function. Its spirocyclic architecture enhances metabolic stability and target binding, making it valuable in the development of therapeutics for conditions such as neuropathic pain, hypertension, and inflammatory diseases. Due to its high potency and favorable pharmacokinetic profile in preclinical models, it serves as a lead compound in drug discovery programs focused on sEH inhibition.